perflubron has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, A; Dennis, JH; El Mays, TY; El Shahat, SG; Fadayomi, M; Green, FHY; Lalli, G; Leigh, R; Nelson, DE; Pieron, CA; Rampakakis, E; Shrestha, G; Swystun, V | 1 |
| Chiu, A; Dennis, JH; El Mays, TY; ElShahat, SG; Fadayomi, M; Green, FH; Lalli, G; Leigh, R; Nelson, DE; Pieron, CA; Shrestha, G | 1 |
2 trial(s) available for perflubron and Asthma
| Article | Year |
|---|---|
A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Alberta; Asthma; Bronchoconstriction; Bronchodilator Agents; Carbon Dioxide; Cross-Over Studies; Double-Blind Method; Expectorants; Female; Fluorocarbons; Forced Expiratory Volume; Humans; Hydrocarbons, Brominated; Lung; Male; Oxygen; Proof of Concept Study; Time Factors; Treatment Outcome; Young Adult | 2018 |
A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers.
Topics: Administration, Inhalation; Adolescent; Adult; Asthma; Bronchoconstriction; Bronchodilator Agents; Canada; Carbon Dioxide; Cohort Studies; Double-Blind Method; Drug Synergism; Electrocardiography; Female; Fluorocarbons; Healthy Volunteers; Humans; Hydrocarbons, Brominated; Male; Middle Aged; Nebulizers and Vaporizers | 2016 |